OLAnzaPiNE
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
OLAnzaPiNE
Oct 2, 2024, 14:53 |
Blog
Eric Singhi: An opportunity to improve patient education
Eric Singhi shared a post on X: "I'm a big advocate for olanzapine and its…
Aug 14, 2024, 07:33 |
Insight
Olanzapine as antiemetic prophylaxis in chemotherapy
Elisa Agostinetto shared on X: "Olanzapine as antiemetic prophylaxis in chemotherapy. In this randomized phase…
Aug 12, 2024, 06:05 |
Insight
Results suggest olanzapine should be a standard to reduce chemotherapy-induced nausea and vomiting
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust shared a post on…
Jul 21, 2024, 21:49 |
Blog
Mark Lewis: Consider Olanzapine for chemotherapy-induced nausea/vomiting
Mark Lewis posted on X/Twitter about a recent paper by Jyoti Bajpai et al., commenting: "I…
Dec 16, 2023, 18:18 |
Insight
SABCS23 Day 2 Highlights by Oncology Brothers
Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the second day's…
All:
5
Posts:
1 - 100
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube